Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years
- PMID: 8385442
- PMCID: PMC1242804
- DOI: 10.1097/00000658-199304000-00009
Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years
Abstract
Objective: This study analyzed the results in 229 patients with primary hepatocellular carcinoma (HCC) who were treated by radical hepatic resection in the past 11 years.
Summary background data: Due to marked advances in diagnostic and therapeutic methods, the therapeutic strategy for HCC has changed significantly. However, there are still many problems to be solved when hepatic resection is to be performed for HCC associated with chronic liver disease. A satisfactory result may be possible only when all of accurate operative indication, skillful surgical technique, and sophisticated postoperative management are met.
Methods: There were 188 men and 41 women. Age ranged from 32 to 79 years averaging 60.8. Underlying cirrhosis of the liver was found in 177 patients, and chronic hepatitis was found in 47 instances. Before surgery, 114 patients had 157 associated conditions; diabetes mellitus in 66, esophageal varices in 42, cholelithiasis in 22, peptic ulcer in 12, and miscellaneous in 15 cases. In addition to various types of hepatic resection, 69 patients underwent concomitant operations such as cholecystectomy, the Warren shunt, splenectomy, partial gastrectomy, and so forth.
Results: The 30-day (operative) mortality rate was 7.0%, and there were eight additional late deaths (3.5%). Child's class, bromosulphalein (BSP) test, and the estimated blood loss during surgery were good predictors for operative death. The cumulative 5- and 10-year survival rates for all patients were 26.4% and 19.4%, respectively. At present, 110 patients are alive; 2 more than 10 years and 21 more than 5 years. Younger age, absence of cirrhosis, smaller tumor, and postoperative chemotherapy were associated with increased survival.
Conclusions: The results of hepatic resection in 229 patients with HCC were analyzed. Child's class, BSP test, and blood loss during surgery were good predictors for operative death. The 5- and 10-year survival rates were 26.4% and 19.4%, respectively. Age, liver cirrhosis, tumor size, and postoperative chemotherapy were prognostic factors. Multidisciplinary approach with liver resection, postoperative chemotherapy, and liver transplantation will be a realistic direction for the surgical treatment of HCC in future.
Similar articles
-
Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis.Ann Surg. 1999 Jan;229(1):84-90. doi: 10.1097/00000658-199901000-00011. Ann Surg. 1999. PMID: 9923804 Free PMC article.
-
Appraisal of hepatic resection in the treatment of minute hepatocellular carcinoma associated with liver cirrhosis.Br J Surg. 1987 Sep;74(9):836-8. doi: 10.1002/bjs.1800740930. Br J Surg. 1987. PMID: 2822200
-
Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis.Arch Surg. 1995 Feb;130(2):198-203. doi: 10.1001/archsurg.1995.01430020088017. Arch Surg. 1995. PMID: 7848092
-
Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis.J Surg Oncol. 2002 Dec;81(4):195-202. doi: 10.1002/jso.10178. J Surg Oncol. 2002. PMID: 12451624 Review.
-
[Hepatic resection for hepatocellular carcinoma--results and analysis of the current literature].Zentralbl Chir. 2009 Apr;134(2):127-35. doi: 10.1055/s-0028-1098881. Epub 2009 Apr 20. Zentralbl Chir. 2009. PMID: 19382043 Review. German.
Cited by
-
Multidisciplinary comprehensive treatment of massive hepatocellular carcinoma with hemorrhage: A case report and review of literature.World J Gastrointest Oncol. 2024 May 15;16(5):2225-2232. doi: 10.4251/wjgo.v16.i5.2225. World J Gastrointest Oncol. 2024. PMID: 38764847 Free PMC article.
-
Vinorelbine Improves the Efficacy of Sorafenib against Hepatocellular Carcinoma: A Promising Therapeutic Approach.Int J Mol Sci. 2024 Jan 26;25(3):1563. doi: 10.3390/ijms25031563. Int J Mol Sci. 2024. PMID: 38338842 Free PMC article.
-
Nomogram for predicting overall survival in patients with large (>5 cm) hepatocellular carcinoma based on real-world practice.J Liver Cancer. 2023 Sep;23(2):350-361. doi: 10.17998/jlc.2023.08.10. Epub 2023 Sep 6. J Liver Cancer. 2023. PMID: 37670423 Free PMC article.
-
Comparable and Complimentary Modalities for Treatment of Small-Sized HCC: Surgical Resection, Radiofrequency Ablation, and Microwave Ablation.J Clin Med. 2023 Jul 29;12(15):5006. doi: 10.3390/jcm12155006. J Clin Med. 2023. PMID: 37568408 Free PMC article. Review.
-
Peroxisome proliferator-activated receptor gamma coactivator 1-alpha protects a fibrotic liver from partial hepatectomy-induced advanced liver injury through regulating cell cycle arrest.Basic Clin Pharmacol Toxicol. 2022 Feb;130(2):254-267. doi: 10.1111/bcpt.13697. Epub 2021 Dec 16. Basic Clin Pharmacol Toxicol. 2022. PMID: 34845850 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous